MA43415A - Arnm modifié codant pour une uridine diphosphate glucuronosyltransférase et utilisations associées - Google Patents

Arnm modifié codant pour une uridine diphosphate glucuronosyltransférase et utilisations associées

Info

Publication number
MA43415A
MA43415A MA043415A MA43415A MA43415A MA 43415 A MA43415 A MA 43415A MA 043415 A MA043415 A MA 043415A MA 43415 A MA43415 A MA 43415A MA 43415 A MA43415 A MA 43415A
Authority
MA
Morocco
Prior art keywords
modified rna
uridine diphosphate
rna coding
associated uses
diphosphate glucuronosyltransferase
Prior art date
Application number
MA043415A
Other languages
English (en)
Inventor
Christian Cobaugh
Melissa Lasaro
David Osterman
Haren Vasavada
Original Assignee
Modernatx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Modernatx Inc filed Critical Modernatx Inc
Publication of MA43415A publication Critical patent/MA43415A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/01—Hexosyltransferases (2.4.1)
    • C12Y204/01017—Glucuronosyltransferase (2.4.1.17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7115—Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
MA043415A 2015-12-09 2016-12-09 Arnm modifié codant pour une uridine diphosphate glucuronosyltransférase et utilisations associées MA43415A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562265174P 2015-12-09 2015-12-09

Publications (1)

Publication Number Publication Date
MA43415A true MA43415A (fr) 2018-10-17

Family

ID=57758709

Family Applications (1)

Application Number Title Priority Date Filing Date
MA043415A MA43415A (fr) 2015-12-09 2016-12-09 Arnm modifié codant pour une uridine diphosphate glucuronosyltransférase et utilisations associées

Country Status (4)

Country Link
US (1) US20190307857A1 (fr)
EP (1) EP3386533A1 (fr)
MA (1) MA43415A (fr)
WO (1) WO2017100562A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020056239A1 (fr) * 2018-09-14 2020-03-19 Modernatx, Inc. Polynucléotides codant pour le polypeptide a1, de la famille de l'uridine diphosphate glycosyltransférase 1, pour le traitement du syndrome de crigler-najjar

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
LT2578685T (lt) * 2005-08-23 2019-06-10 The Trustees Of The University Of Pennsylvania Rnr, apimančios modifikuotus nukleozidus ir jų panaudojimo būdai
AU2006330858A1 (en) 2005-12-21 2007-07-05 Wyeth Protein formulations with reduced viscosity and uses thereof
PT2506857T (pt) 2009-12-01 2018-05-14 Translate Bio Inc Entrega de arnm para o acréscimo de proteínas e enzimas em doenças genéticas humanas
WO2012075040A2 (fr) 2010-11-30 2012-06-07 Shire Human Genetic Therapies, Inc. Arnm pour l'utilisation dans le traitement de maladies génétiques humaines
WO2012129648A1 (fr) 2011-03-25 2012-10-04 University Of Guelph Activation d'expression de protéines de vecteurs de virus adéno-associés
RS63244B1 (sr) 2011-12-16 2022-06-30 Modernatx Inc Kompozicije modifikovane mrna
CN108949772A (zh) * 2012-04-02 2018-12-07 现代泰克斯公司 用于产生与人类疾病相关的生物制剂和蛋白质的修饰多核苷酸
EP2833892A4 (fr) 2012-04-02 2016-07-20 Moderna Therapeutics Inc Polynucléotides modifiés destinés à la production de protéines et de peptides associés à l'oncologie
JP6561378B2 (ja) 2012-06-08 2019-08-21 トランスレイト バイオ， インコーポレイテッド 非肺標的細胞へのｍＲＮＡの経肺送達
ES2921623T3 (es) 2012-11-26 2022-08-30 Modernatx Inc ARN modificado terminalmente
CN114395559A (zh) * 2014-04-25 2022-04-26 吉尼松公司 高胆红素血症的治疗

Also Published As

Publication number Publication date
EP3386533A1 (fr) 2018-10-17
WO2017100562A1 (fr) 2017-06-15
WO2017100562A9 (fr) 2017-08-03
US20190307857A1 (en) 2019-10-10

Similar Documents

Publication Publication Date Title
GB201715242D0 (en) Waveguide modulator structures
SI3245346T1 (sl) Betonski strop
DK3296597T3 (da) Krydshovedmotor
SG11201708196PA (en) Piling construction management method
MA49684A (fr) Arnm modifié codant une glucose-6-phosphatase et utilisations associées
MA49634A (fr) Arnm modifié codant pour une propionyl-coa-carboxylase et utilisations associées
PL4030014T3 (pl) Wkładka dystansowa ścienna
MA43415A (fr) Arnm modifié codant pour une uridine diphosphate glucuronosyltransférase et utilisations associées
MA40429A (fr) Gabion
FI20156045A (fi) Kationinen pintaliima-aine
FR3042207B1 (fr) Bloc de construction
HU4788U (hu) Építõelem-készlet
ES1147135Y (es) Pala de aerogenerador
ITUB20152029A1 (it) Benna frantumatrice
AU201713207S (en) Concrete Form Spacer
IT201600131099A1 (it) Pannello fonoassorbente perfezionato.
GB201507312D0 (en) Quantum hardened cryptosystem
UA32418S (uk) Молоток
UA32417S (uk) Молоток
PT3341535T (pt) Elementos de espaçamento para armaduras de betão
GB201512552D0 (en) Keys / locks
TWD174439S (zh) 鎖匙
UA32424S (uk) Зубило
HU5021U (hu) Kötõanyag nélküli falazóelem
FI10998U1 (fi) Putkilapio